TP53BP1 and cervical carcinoma: Altogether, our results indicate a differential requirement for ATM or 53BP1 with respect to irradiation-induced cell cycle arrest and show that ATM inhibition dramatically radiosensitises cervical cancer cells as judged by survival assays.